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Lithium is an effective therapeutic agent used in the management of bipolar disorder. However, lithium is
also associated with several side effects, including renal toxicity. We present a case of a symptomatic
cystic mass lesion in the kidney of a patient who had a history of lithium therapy for the management of
bipolar disorder.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Lithium is an effective therapeutic agent used in the manage-
ment of bipolar disorder. However, lithium is also associated with
several side effects, including renal toxicity. Chronic tubulointer-
stitial nephropathy is the predominant form of chronic renal dis-
ease secondary to lithium. In addition, the development of renal
cysts is highly characteristic of lithium toxicity, occurring in up to
40% of cases.1
We present a case of a symptomatic multicystic mass lesion in
the kidney of a patient who had a history of lithium therapy for the
management of bipolar disorder.Case presentation
A 45-year-old gentleman presented to the emergency depart-
ment with frank hematuria. Imaging was performed, which
revealed a left enhancing multicystic renal mass (Fig. 1). Renal
function was normal, and there was no signiﬁcant family history.
The patient had a history of long-term lithium treatment for bipolar
affective disorder.
The patient underwent a left nephrectomy. Macroscopic exam-
ination revealed a 35-mm cystic mass in the lower pole of the
kidney (Fig. 2). There were no solid areas identiﬁed, and the back-
ground kidney was unremarkable.BY-NC-ND license (http://
: þ353-18092955.
y).
Published by Elsevier Inc. All righHistologic examination showed the lesion to be composed of
multiple variably sized cysts lined by bland cuboidal epithelium,
with less prominently dilated cystic spaces present more diffusely
(Fig. 3). There was no evidence of malignancy. The background
renal parenchyma showed approximately 15% glomerulosclerosis,
mild interstitial ﬁbrosis, chronic interstitial nephritis, and arterial
nephrosclerosis.
Immunohistochemistry was performed which showed CAM5.2
positivitywithin the cystically dilated area aswell aswithin the cystic
tubules, suggesting that these regions are of distal nephron origin.Discussion
Lithium is a therapeutic agent used in the prophylaxis and
treatment of mania, hypomania, and depression in bipolar disor-
der.1,2 The efﬁcacy of lithium for treating mania was discovered in
1949, making it the ﬁrst medication speciﬁcally developed for the
treatment of bipolar disorder.1 Lithium remains in widespread use
in the management of bipolar disorder today. Lithium has a narrow
therapeutic to toxic ratio and therefore requires monitoring of
serum lithium concentrations.3 Although lithium is an important
and highly effective agent, it is associated with many acute and
long-term adverse effects.3 A frequent side effect of lithium is renal
toxicity.
Lithium is excreted almost entirely by the kidneys and is freely
ﬁltered by the glomeruli. A small fraction is reabsorbed in distal
parts of the nephron through the epithelial sodium channel.3
Lithium, unlike sodium, is not exported from the cell and accu-
mulates intracellularly, which results in dysregulation of the
vasopressin-regulated water channel, aquaporin 2 (AQP2), which ists reserved.
Figure 1. Computed tomography scan showing enhancing multicystic renal mass.
Figure 3. Cystic lesion lined by bland cuboidal epithelium.
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the collecting duct.3
Nephrogenic diabetes insipidus is the most common renal side
effect of lithium therapy. Nephrogenic diabetes insipidus occurs in
up to 20%-40% of patients on lithium therapy.1 Long-term lithium
ingestion can lead to resistance to antidiuretic hormone, resulting
in polyuria and polydipsia, which can result in signiﬁcant volume
depletion. Lithium enters and accumulates in the principal cells of
the collecting duct, where it promotes the inhibition of glycogen
synthase kinase 3, an enzyme that controls the transport of water
and sodiumvia AQP2 and epithelial sodium channel, respectively.1,3
This results in the cell becoming at least partially insensitive to theFigure 2. Nephrectomy specimen showing cystic lesion.actions of vasopressin and aldosterone, thereby interfering with the
ability of the cell to increase water permeability. Furthermore, by
downregulating AQP2, this leads to an additional decrease in
concentrating ability.2
Lithium therapy may also result in glomerular toxicity and focal
segmental glomerulosclerosis has been reported in up to 50% of
renal biopsies from patients on lithium therapy.2
The predominant form of chronic renal disease associated with
lithium therapy is chronic tubulointerstitial nephropathy (CTIN). The
histologic ﬁndings in patients with lithium-induced CTIN include
tubular atrophy and interstitial ﬁbrosis, which are typically out of
proportion to the degree of glomerulosclerosis and vascular disease.2
In addition to the relatively nonspeciﬁc ﬁndings of CTIN, the
presence of tubular cysts is highly characteristic of lithium toxicity,
occurring in up to 62.5% of cases, with a lesser degree of tubular
dilatation occurring in an additional 33.3% of biopsies.1,2 In a study
by Markowitz et al,2 immunohistochemical and lectin staining
revealed tubular cysts of predominantly distal tubular and col-
lecting duct origin. This ﬁnding is not unexpected based on the
predominantly distal nephron toxicity of lithium.
In our case report, histologic examination of the kidney showed
the lesion to be composed of multiple, variably sized cysts, lined by
bland cuboidal epithelium. Immunohistochemistry studies
revealed CAM5.2 positivity within the cystically dilated area as well
as within the cystic tubules, suggesting that these regions are of
distal nephron origin. This is in keeping with the previous studies,
which have demonstrated the tubular cysts to be of distal and
collecting tubular origin.2
In most cases, lithium-induced renal cysts appear as multiple
bilateral microcysts (measuring from 1 to 2 mm) on magnetic
resonance imaging.4 Imaging in our case showed a multicystic
enhancing renal mass, the differential diagnosis for which included
renal cell carcinoma. A biopsy was not performed, and the patient
underwent a left nephrectomy. Histology showed a complicated
cystic lesion with no evidence of malignancy.
Recently, research has suggested that prolonged lithium therapy
is not only associated with cyst formation but can also lead to the
formation of adenomas and carcinomas.5 In a study by Rookmaaker
et al, they reported 6 cases of lithium-associated tumors, all of
which were of collecting duct origin, similar to the origin of the
benign cystic lesions.5 This highlights the importance of adequate
sampling of renal lesions in a patient with a history of lithium
therapy to rule out the presence of a neoplastic lesion.
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Long-term lithium therapy is associated with renal toxicity. The
present case report highlights the risk of development of compli-
cated renal cysts due to lithium therapy. Lithium-induced renal
cysts can present as symptomatic mass lesions on imaging, the
differential diagnosis for which includes renal cell carcinoma. It is
important to consider lithium nephrotoxicity in histologic exami-
nation of renal lesions in a patient with a history of bipolar disorder
and lithium therapy.Consent
Informed consent was obtained from the patient for publication
of this case report and any accompanying images.Conﬂict of interest
All the authors declare that there are no conﬂicts of interests
regarding the publication of this article.
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